COMMUNIQUÉS West-GlobeNewswire

DBV Technologies Announces Appointment of Michel de Rosen as Non-Executive Chairman of the Board of Directors
05/03/2019
Montrouge, France, March 5, 2019 DBV Technologies Announces Appointment of Michel de Rosen as Non-Executive Chairman of the Board of Directors Mr. de Rosen to succeed DBV’s co-founder, Dr. Pierre-Henri Benhamou, who [...]
DBV Technologies annonce la nomination de Michel de Rosen en tant que Président non-exécutif du conseil d'administration
05/03/2019
Montrouge, France, 5 mars (7 h 30 CET) 2019 DBV Technologies annonce la nomination de Michel de Rosen en tant que Président non-exécutif du conseil d'administration Michel de Rosen succède au co-fondateur de DBV, le Dr [...]
Novartis Cosentyx® shows superior improvements in psoriasis patients' quality of life versus Janssen's IL-23 Stelara®*
05/03/2019
New CLARITY data show over two-thirds of Cosentyx (secukinumab) treated patients with moderate to severe psoriasis reported no impact of skin disease on their quality of life (QoL) up to Week 16 compared to Stelara [...]
MDxHealth : SelectMDx® Liquid Biopsy Test for Prostate Cancer Included in the 2019 Italian Society of Urology Guidelines
05/03/2019
NEWS RELEASE MDxHealth's SelectMDx ® Liquid Biopsy Test for Prostate Cancer Included in the 2019 Italian Society of Urology Guidelines A significant milestone to increase adoption of SelectMDx in Italy IRVINE, CA, and [...]
Darolutamide submitted for marketing authorization in Japan
05/03/2019
Orion Corporation Press release 5 March 2019 at 8.00 a.m. EET Darolutamide submitted for marketing authorization in Japan Regulatory submission based on positive data from the Phase III ARAMIS trial Orion Corporation [...]
ObsEva Reports Fourth Quarter and Full Year 2018 Financial Results, Provides Business Update
05/03/2019
Major 2018 Accomplishments Driven by Positive Clinical Trial Results - Significant increase in rates of pregnancy and live birth (up to 35% increase in Day 5 ET) in Phase 3 IMPLANT 2 trial of nolasiban in IVF procedures [...]
Bone Therapeutics SA: Information on the total number of voting rights and shares
05/03/2019
Regulated information Gosselies, Belgium, 5 March 2019, 7am CET – BONE THERAPEUTICS (Euronext Brussels and Paris: BOTHE), the bone cell therapy company addressing high unmet medical needs in orthopaedics and bone [...]
Bone Therapeutics SA : Information relative au nombre total de droits de vote et d’actions
05/03/2019
Information réglementée Gosselies, Belgique, le 5 mars 2019, 07h00 CET - BONE THERAPEUTICS (code Euronext Bruxelles et Paris : BOTHE), société de thérapie cellulaire osseuse qui répond à d’importants besoins médicaux [...]
Alder BioPharmaceuticals, Inc. Announces Closing of Public Offering and Private Placement of Common Stock and Exercise in Full of Option to Purchase Additional Shares
05/03/2019
BOTHELL, Wash., March 04, 2019 (GLOBE NEWSWIRE) -- Alder BioPharmaceuticals, Inc. (NASDAQ: ALDR), a biopharmaceutical company focused on developing novel therapeutic antibodies for the treatment of migraine, announced [...]
MULTIMEDIA UPDATE - AHIMA Joins with Artifact Health, Provides Standardized, Compliant Templates For Platform that Streamlines Time-Consuming Physician Queries
05/03/2019
CHICAGO and BOULDER, Colo., March 04, 2019 (GLOBE NEWSWIRE) -- The American Health Information Management Association (AHIMA) has joined with Artifact Health to provide and maintain a comprehensive library of compliant [...]
aTyr Pharma Announces Participation at March Investor Conferences
04/03/2019
SAN DIEGO, March 04, 2019 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel immunological pathways, today [...]
Psychemedics Corporation Announces 3rd Straight Year of Record Revenue; Declares 90th Consecutive Quarterly Dividend
04/03/2019
ACTON, Mass., March 04, 2019 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ:PMD) today announced fourth quarter and year-end financial results for the period ended December 31, 2018. The Company also announced a [...]
Kezar Life Sciences Strengthens Management Team, Appoints Celia Economides as Senior Vice President, Strategy and External Affairs
04/03/2019
SOUTH SAN FRANCISCO, Calif., March 04, 2019 (GLOBE NEWSWIRE) -- Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company discovering and developing novel small molecule therapeutics to treat unmet [...]
Sientra® to Release Fourth Quarter and Full Year 2018 Financial Results on March 12, 2019
04/03/2019
SANTA BARBARA, Calif., March 04, 2019 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN), a medical aesthetics company (“Sientra or the “Company”), announced today that the Company will release its fourth quarter and full [...]
Adamas Reports Recent Achievements and Financial Results for the Fourth Quarter and Full-Year 2018
04/03/2019
EMERYVILLE, Calif., March 04, 2019 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS) today reported recent achievements and financial results for the fourth quarter and full-year ended December 31, 2018, [...]
Genesis to Present at the Barclays Global Healthcare Conference on March 12, 2019; Expects to Release Fourth Quarter and Year End 2018 Results on March 18, 2019
04/03/2019
KENNETT SQUARE, Pa., March 04, 2019 (GLOBE NEWSWIRE) -- Genesis HealthCare (NYSE:GEN) (Genesis or the Company), one of the nation’s largest providers of post-acute care, today announced that George V. Hager, Jr., Chief [...]
Proteon Therapeutics to Present at the Cowen and Company 39th Annual Health Care Conference on March 11th
04/03/2019
WALTHAM, Mass., March 04, 2019 (GLOBE NEWSWIRE) -- Proteon Therapeutics Inc. (Nasdaq: PRTO), a company developing novel, first-in-class therapeutics to address the medical needs of patients with kidney and vascular [...]
Flexion Therapeutics to Present at the Cowen 39th Annual Health Care Conference
04/03/2019
BURLINGTON, Mass., March 04, 2019 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq:FLXN) announced today that Michael Clayman, M.D., President and Chief Executive Officer, will present at the Cowen 39 th Annual [...]
Important New Data on Vascepa® (Icosapent Ethyl) from the REDUCE-IT™ Trial to Be Presented Regarding Reduction in Total Ischemic Events
04/03/2019
Multiple Scientific Presentations Scheduled for American College of Cardiology’s 68th Annual Scientific Session Amarin to Webcast Discussion of Presented Data March 18, 4:00-5:00 pm Central Time BEDMINSTER, N.J., and [...]

Pages